Colorectal
Colorectal cancer, also known as bowel cancer, colon cancer, or rectal cancer, is any cancer that affects the colon and the rectum. The American Cancer Society estimate that about 1 in 21 men and 1 in 23 women in the United States will develop colorectal cancer during their lifetime.
Showing all 7 results
-
AVASTIN (bevacizumab) Solution for intravenous infusion. Initial U.S. Approval: 2004
Read more -
Bevacizumab Injection. Initial U.S. Approval: 2004
Read more -
CYRAMZA (ramucirumab) injection, for intravenous use. Initial U.S. Approval: 2014
Read more -
FRUZAQLA (fruquintinib) capsules
Read more -
KEYTRUDA (pembrolizumab) injection, for intravenous use
Read more -
LONSURF (trifluridine and tipiracil) tablets, for oral use. Initial U.S. Approval: 2015
Read more -
VEGZELMA (bevacizumab-adcd) injection
Read more